Early stage IT and Healthcare Investing

PMV Pharma

portfoliocompanies

company snapshot

PMV Pharma is developing first-in-class p53 and p53 pathway modulators for the treatment of cancer and infectious disease. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus.

website
http://www.pmvpharma.com
Leadership
Follow The Company
Investment Team
David Mack, Co-Founder, President & CEO
Facebook Google+ Twitter Email LinkedIn Share